Impacts of the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain on Opioid Prescribing and Pain Management Outcomes: A Systematic Review

Author(s)

Kang HA1, Zhang Y1, Lu A1, Shukla N2
1The University of Texas at Austin, Austin, TX, USA, 2AbbVie, Wheeling, IL, USA

Presentation Documents

OBJECTIVES: In March 2016, the Centers for Disease Control and Prevention (CDC) released the Guideline for Prescribing Opioids for Chronic Pain to promote safer and more effective use of prescription opioids for adult patients with chronic pain outside of active cancer treatment, palliative care, and end-of-life care. We aimed to synthesize the literature on changes in opioid prescribing and pain management following the publication of the guidelines.

METHODS: We adopted the standard systematic review procedures. Studies that used real-world data to examine the impacts of the guidelines on opioid prescribing or pain management outcomes and were published between March 2016 and May 2023 were searched in five databases, including PubMed and Web of Science. Included studies were categorized based on the study population and reported outcomes.

RESULTS: A total of 23 articles met the inclusion criteria. The studies examined the impacts of the guidelines on various populations, both intended and unintended groups of the guidelines, including those with chronic pain (n=5), acute pain (n=1), any non-cancer pain conditions (n=3), cancer (n=3), surgery (n=2), and opioid-naïve individuals (n=8). The reported opioid prescribing outcomes before and after the guideline release included: the prevalence or incidence of opioid prescriptions, opioid dose, the number of days’ supply, concurrent opioid and benzodiazepine prescriptions, and tapering and rapid discontinuation. Two studies examined the impacts of the guidelines on pain-management outcomes. Except for one study that assessed the likelihood of tapering and rapid discontinuation, all of the included studies reported declines in opioid prescription practices in at least one of the opioid prescription outcomes across different populations.

CONCLUSIONS: The release of the 2016 CDC guidelines was associated with decreases in various opioid prescribing outcomes in both intended and unintended groups of patients. There is a gap in the literature regarding the impacts of the guidelines on pain management outcomes.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)

Code

HPR101

Topic

Study Approaches

Topic Subcategory

Literature Review & Synthesis

Disease

Drugs, No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×